Improved medical care of congenital heart disease patients increased survival into
adulthood from 15% in the 1960s to over 85% in the current era. As a consequence, the …

Background Most congenital heart diseases (CHDs) have specific hemodynamics, including
volume and pressure overload, as well as cyanosis and pulmonary hypertension …

Background COVID19 patients may suffer from multiple cardiovascular complications.
Recently, N-terminal of the prohormone brain natriuretic peptide (NT-proBNP) was a …

Introduction: Paediatric heart failure is a common clinical syndrome that may be experienced
by children with congenital heart disease (CHD) and/or cardiomyopathy. It is characterised …

Aims To quantify the ability of N-terminal pro-brain natriuretic peptide (NT pro-BNP) to
predict mortality and hospitalization in patients with chronic obstructive airways disease …

Context: Newborns with congenital hypothyroidism (CH) have an increased risk for
congenital heart defects (CHD) due to a common embryonic developmental program …

Although N-terminal pro-brain natriuretic peptide (NT-proBNP) is a useful screening test of
impaired right ventricular (RV) function in conditions affecting the right-sided cardiac muscle …

Brain natriuretic peptide and N-terminal pro-brain natriuretic peptide are two well-
established markers for cardiac failure in acquired heart disease. Nevertheless, the clinical …

Abstract Purpose of Review There is an increasing number of adult patients with congenital
heart disease (CHD). While several biomarkers have been validated and integrated into …

Major causes of heart failure (HF) in adults with acquired heart disease are myocardial
ischemia, systemic hypertension, valvular disease and cardiomyopathies for left-sided HF …